| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the development of entry inhibitors for sialic-acid-targeting viruses
|
Heida, Rick
|
|
|
26 |
1 |
p. 122-137
|
artikel
|
| 2 |
Advancing automation in Compound Management: a novel industrial process underpinning drug discovery
|
Green, Clive P.
|
|
|
26 |
1 |
p. 5-9
|
artikel
|
| 3 |
Artificial intelligence in drug discovery and development
|
Paul, Debleena
|
|
|
26 |
1 |
p. 80-93
|
artikel
|
| 4 |
Clearance prediction for Amgen molecules against Extended Clearance Classification System (ECCS) and future directions
|
Agarwal, Prashant
|
|
|
26 |
1 |
p. 10-16
|
artikel
|
| 5 |
Contents page 1
|
|
|
|
26 |
1 |
p. i
|
artikel
|
| 6 |
Contents page 2
|
|
|
|
26 |
1 |
p. ii
|
artikel
|
| 7 |
Decoding (patho-)physiology of the lung by advanced in vitro models for developing novel anti-infectives therapies
|
Montefusco-Pereira, Carlos Victor
|
|
|
26 |
1 |
p. 148-163
|
artikel
|
| 8 |
Deep learning in next-generation sequencing
|
Schmidt, Bertil
|
|
|
26 |
1 |
p. 173-180
|
artikel
|
| 9 |
3D engineering for optic neuropathy treatment
|
Xuan, Wenjing
|
|
|
26 |
1 |
p. 181-188
|
artikel
|
| 10 |
Design of bivalent ligands targeting putative GPCR dimers
|
Huang, Boshi
|
|
|
26 |
1 |
p. 189-199
|
artikel
|
| 11 |
Dual-acting therapeutic proteins for intraocular use
|
Collins, Matthew
|
|
|
26 |
1 |
p. 44-55
|
artikel
|
| 12 |
Electrochemical biosensors: a nexus for precision medicine
|
Pollard, Thomas D.
|
|
|
26 |
1 |
p. 69-79
|
artikel
|
| 13 |
Entolimod as a radiation countermeasure for acute radiation syndrome
|
Singh, Vijay K.
|
|
|
26 |
1 |
p. 17-30
|
artikel
|
| 14 |
Human-based evidence for the therapeutic potential of arginase inhibitors in cardiovascular diseases
|
Moretto, Johnny
|
|
|
26 |
1 |
p. 138-147
|
artikel
|
| 15 |
Immunotherapies in cutaneous pathologies: an overview
|
Baylet, Audrey
|
|
|
26 |
1 |
p. 248-255
|
artikel
|
| 16 |
Labeling and tracking cells with gold nanoparticles
|
Chandrasekaran, Ramya
|
|
|
26 |
1 |
p. 94-105
|
artikel
|
| 17 |
Long noncoding RNAs in cancer immunity: a new avenue in drug discovery
|
Dutta, Anindya
|
|
|
26 |
1 |
p. 264-272
|
artikel
|
| 18 |
Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance
|
Vanamala, Kushal
|
|
|
26 |
1 |
p. 31-43
|
artikel
|
| 19 |
Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase
|
Yao, Hang-Ping
|
|
|
26 |
1 |
p. 106-121
|
artikel
|
| 20 |
Public funding for transformative drugs: the case of sofosbuvir
|
Barenie, Rachel E.
|
|
|
26 |
1 |
p. 273-281
|
artikel
|
| 21 |
Rodent models of diabetic kidney disease: human translatability and preclinical validity
|
Sembach, Frederikke E.
|
|
|
26 |
1 |
p. 200-217
|
artikel
|
| 22 |
Sources of innovation for new medicines: questions of sustainability
|
Kinch, Michael S.
|
|
|
26 |
1 |
p. 240-247
|
artikel
|
| 23 |
Tetraspanins: useful multifunction proteins for the possible design and development of small-molecule therapeutic tools
|
Robert, Jean-Michel H.
|
|
|
26 |
1 |
p. 56-68
|
artikel
|
| 24 |
The innovative potential of selenium-containing agents for fighting cancer and viral infections
|
Ali, Wesam
|
|
|
26 |
1 |
p. 256-263
|
artikel
|
| 25 |
The multifunctional APE1 DNA repair–redox signaling protein as a drug target in human disease
|
Caston, Rachel A.
|
|
|
26 |
1 |
p. 218-228
|
artikel
|
| 26 |
The present and future of project management in pharmaceutical R&D
|
Schuhmacher, Alexander
|
|
|
26 |
1 |
p. 1-4
|
artikel
|
| 27 |
Transcription factor EB: an emerging drug target for neurodegenerative disorders
|
Song, Ju-Xian
|
|
|
26 |
1 |
p. 164-172
|
artikel
|
| 28 |
Union is strength: antiviral and anti-inflammatory drugs for COVID-19
|
Naveja, Jose J.
|
|
|
26 |
1 |
p. 229-239
|
artikel
|
Tijdschrift beschrijving